Literature DB >> 24014570

Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.

J Bakshi1, S Hassan, D D'Cruz, A Chan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24014570     DOI: 10.1177/0961203313504634

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  8 in total

1.  Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.

Authors:  Zachary Junga; Rodger Stitt; Christopher Tracy; Michael Keith
Journal:  BMJ Case Rep       Date:  2017-08-21

2.  Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.

Authors:  Ammouri Wafa; Harmouche Hicham; Radi Naoufal; Khibri Hajar; Razine Rachid; Benkirane Souad; Maamar Mouna; Mezalek Tazi Zoubida; Adnaoui Mohamed
Journal:  Clin Rheumatol       Date:  2022-02-18       Impact factor: 2.980

3.  Outcomes of rituximab therapy in refractory lupus: A meta-analysis.

Authors:  Fatma Alshaiki; Elaf Obaid; Abdulqader Almuallim; Rabab Taha; Hadeel El-Haddad; Hani Almoallim
Journal:  Eur J Rheumatol       Date:  2018-02-13

4.  Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.

Authors:  Ai-Chun Liu; Yue Yang; Meng-Tao Li; Yuan Jia; Sheng Chen; Shuang Ye; Xiang-Zong Zeng; Zhao Wang; Jin-Xia Zhao; Xiang-Yuan Liu; Jian Zhu; Yan Zhao; Xiao-Feng Zeng; Zhan-Guo Li
Journal:  Clin Rheumatol       Date:  2017-04-13       Impact factor: 3.650

5.  Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature.

Authors:  Guido Granata; Dario Didona; Giuseppina Stifano; Aldo Feola; Massimo Granata
Journal:  Case Rep Med       Date:  2015-05-07

Review 6.  Immunology of COVID-19 and disease-modifying therapies: The good, the bad and the unknown.

Authors:  Tobias Zrzavy; Isabella Wimmer; Paulus S Rommer; Thomas Berger
Journal:  Eur J Neurol       Date:  2020-11-08       Impact factor: 6.288

7.  Macrophage Activation Syndrome (MAS) in a Recently Released Prisoner with Systemic Lupus Erythematosus (SLE).

Authors:  Robert Szulawski; Peter J Kourlas; Marc Antonchak
Journal:  Am J Case Rep       Date:  2018-06-22

8.  Macrophage Activation Syndrome, Glomerulonephritis, Pericarditis, and Retinal Vasculitis as Initial Presentation of Systemic Lupus Erythematosus.

Authors:  Yiming Luo; Yumeng Wen; Ana Belen Arevalo Molina; Punya Dahal; Lorenz Leuprecht; Makda Bsrat
Journal:  Case Rep Med       Date:  2018-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.